Skip to content

Author

Nagaraj Rangappa

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review 2026

Small molecular therapeutic targets for neurodegenerative diseases.

A deeper understanding of aging-associated molecular dysfunction is essential to design sustainable, disease-modifying therapeutics with cross-disease relevance.

Nagaraj Rangappa, Riddhi Upadhyay, Nathish Lakshman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.